Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00532506
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Brief Summary
The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Treatment-naive subjects diagnosed with type 2 diabetes mellitus
- Stable diet program for at least 8 weeks
- Criteria for HbA1c are met
Read More
Exclusion Criteria
- Type 1 diabetes
- Patients treated with other antidiabetic drugs or Insulin
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method